BioCentury
ARTICLE | Clinical News

Fluvoxamine CR: Began Phase III testing

August 16, 1999 7:00 AM UTC

Solvay Pharmaceuticals Inc., Marietta, Ga. Product: Fluvoxamine CR Business: Neurological Therapeutic category: Neurotransmission Target: Serotonin Description: Controlled-release formulation of Luvo...